HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,111,563 | +6.4% | 157,530 | +1.1% | 0.08% | +13.3% |
Q2 2023 | $13,266,493 | +3.5% | 155,820 | +0.6% | 0.08% | +1.4% |
Q1 2023 | $12,812,750 | +4.9% | 154,836 | -0.3% | 0.07% | +2.8% |
Q4 2022 | $12,217,569 | +2.0% | 155,341 | -4.0% | 0.07% | -5.3% |
Q3 2022 | $11,983,000 | +12.9% | 161,870 | -0.6% | 0.08% | +16.9% |
Q2 2022 | $10,616,000 | -82.7% | 162,861 | -83.2% | 0.06% | -79.9% |
Q1 2022 | $61,388,000 | +26.2% | 971,011 | +5.8% | 0.32% | +32.2% |
Q4 2021 | $48,657,000 | -32.3% | 917,358 | -9.8% | 0.24% | -38.0% |
Q3 2021 | $71,819,000 | +2.3% | 1,017,413 | -3.4% | 0.40% | +5.6% |
Q2 2021 | $70,171,000 | -40.2% | 1,052,983 | -0.4% | 0.37% | -44.5% |
Q1 2021 | $117,420,000 | +5.2% | 1,057,738 | +12.5% | 0.67% | -3.4% |
Q4 2020 | $111,650,000 | – | 940,216 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |